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 ABSTRACT  
 
LINDY LIU 
An Analysis of Household-reported Health Status and Socio-demographic Characteristics 
Associated with Adolescent Influenza Vaccination Rates in the United States: 2008 National 
Immunization Survey- Teen  
(Under the direction of Christine Stauber, Faculty Member)   
 
Background: Influenza is a highly contagious but preventable acute respiratory illness 
associated with high morbidity. Seasonal influenza affects approximately 20% to 40% of 
children and adolescents. Annual influenza vaccination is an effective approach to prevent illness 
but recent studies suggests that adolescents are underutilizing important preventive health 
services and that influenza vaccination coverage in high risk adolescents is also suboptimal. The 
purpose of this study was to examine the association between household reported health status 
and socio-demographic characteristics of U.S. adolescents who reported receiving an influenza 
vaccination.  
 
Methods: Data from the 2008 National Immunization Survey were assessed examining various 
demographic and socioeconomic characteristics, as well as reported health status of non-
institutionalized adolescents in the U.S. The sample was limited adolescents aged 13-17. Odds 
ratios were calculated and multivariate logistic regression was conducted. P-values of < 0.05 and 
95% confidence intervals were used to determine statistical significance.   
 
Results: There were 29063 total observations with 18.9% reporting receiving the influenza 
vaccine. The results of this study indicate that sex, race and ethnicity, poverty status, health 
insurance status, asthma status, having an underlying health condition, missed school days due to 
illness or injury, and maternal age are associated with getting immunized against influenza. As 
one might expect those who reported having health insurance, having asthma, and having an 
underlying health condition had higher likelihood of vaccine. Interestingly, non-Hispanic other 
race and multi-race teens in the study were the most likely to receive the influenza vaccine 
compared with non-Hispanic white teens. 
 
Conclusions: This study further examines the impact of socio-demographic disparities and 
health status on influenza vaccination coverage. Although the current influenza vaccine 
recommendations now include all individuals ages 6 months and older, it should still be 
important to recognize disparities and inequalities which contribute to non-vaccination or under-
vaccination. Improved understanding of demographic and socioeconomic characteristics, as well 
as existing underlying health conditions, will facilitate the path to improving interventions, 
vaccination rates, and subsequent reduction in the burden of this preventable disease.
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1 Background 
Influenza is a preventable and highly contagious viral acute respiratory disease of 
global importance that has caused pandemics of human disease for centuries [1-2]. The 
World Health Organization (WHO) estimates that 3 to 5 million case of severe illness and 
250,000 to 500,000 deaths worldwide are attributed to influenza, and that the direct and 
indirect costs of influenza in industrialized countries are approximately 10-60 million 
United States Dollars per million persons per season [3-4]. Although the severity of an 
influenza season can vary substantially each year, approximately 200,000 hospitalizations 
and 23,000 deaths are caused by influenza in a typical endemic season in the United 
States [5-7].   
People of all ages are afflicted, but the pediatric burden is considerable and the 
prevalence is greatest in school-age children [7-8]. Approximately 20% to 40% of 
children and adolescents are affected by influenza each year [9]. In children with high-
risk health conditions, the disease accounts for 2 to 4 times higher rates of 
hospitalizations, 120 to 200 outpatient visits, and 65-140 antibiotic courses per 1000 
children per year [10].  Although influenza-associated pediatric mortality is rare and 
children with risk factors for influenza complications are at highest risk for death, many 
influenza infections are not diagnosed clinically and the majority of pediatric deaths have 
occurred among previously healthy children without any known high-risk conditions
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[11-12].  In addition, recent studies have shown an increase in bacterial co-infections in 
influenza-associated pediatric cases where children were significantly older and more 
likely to have pneumonia [11]. 
Annual influenza vaccination is the most effective strategy for preventing infection 
and decreasing transmission within communities [13]. Routine vaccination of children, 
health-care professionals, and other individuals who could serve as a source of influenza 
virus transmission provides additional protection to persons at risk for influenza 
complications and reduces the overall influenza burden [13]. High vaccination coverage 
in school-aged children not only provides indirect protection to families, unimmunized 
classmates, and school staff, but it may also benefit schools by reducing student and 
teacher absenteeism [14].  
 Although seasonal influenza is the most common cause of vaccine-preventable death 
in the Unites States, vaccination rates remain low for all categories of people at highest 
risk [15-16]. Despite the burden of disease, the development of safe and effective 
vaccines, and long-standing vaccination recommendations by the Advisory Committee on 
Immunization Practices (ACIP), studies have revealed that influenza vaccination 
coverage among children and adolescents with high-risk conditions ranges only from 9% 
to 31% [15, 17]. Although there are many vaccine mandates for the pediatric population 
in the United States, there are no known influenza vaccination mandates for students 
enrolled in school or day care. Currently,  requirements only exist in long-term care 
facilities in select states [18]. Even with vaccine recommendations and public service 
announcements that explain the benefits of vaccines, there remains a subset of the 
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population who declines vaccinations because of religious beliefs, personal preferences, 
and freedom of choice [19].  
1.2 Purpose of Study 
 Influenza illness severity, mortality, healthcare costs, and productivity losses are 
greatest in high-risk groups, but cost and lost productivity among non-high-risk groups 
are also considerable [20]. Adolescent youth are an active and collective group, and play 
an important role in the spread of disease, but studies suggest that adolescents do not 
access health care regularly despite recommendations for annual health care-visits [21-
22]. Strategies and programs to reduce missed opportunities in physicians’ offices to 
improve vaccine coverage have had limited success [14].  
Substantial disparities attributed to demographic and socio-economic status exists in 
the receipt of annual influenza vaccination, and interventions do not cover those who do 
not seek regular medical care or those who are not insured [23]. Secondly, mothers are 
often strongly influential in the vaccination of their children and assume primary 
responsibility for their children’s preventive health services [24].  If adolescents are 
underutilizing important preventive health services, and if influenza vaccination coverage 
in high-risk adolescents is suboptimal, it is important to examine and characterize this 
population to increase coverage. Therefore an understanding of the socio-demographic 
characteristics, including maternal socio-demographic characteristics, as well as 
household-reported health status in adolescents may provide opportunity for targeted 
approaches to reduce the health disparities for influenza vaccination and ultimately the 
burden of disease. 
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1.3 Research Question  
To further investigate predictors of why adolescents aged 13 to 17 in the 2008 
National Immunization Survey- Teen receive the influenza vaccine, the following 
questions will be examined: 
1. What are the demographic characteristics of adolescents who receive influenza 
vaccinations?  
2. What are the socioeconomic characteristics of adolescents who receive influenza 
vaccinations? 
3. What are the household-reported health status of adolescents who receive 
influenza vaccinations?  
4. What are the maternal socio-demographic characteristics of adolescents who 
receive influenza vaccinations? 
5. Do the typical trends of social determinants of health also apply to influenza 
vaccination trends?  
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Chapter II 
 
REVIEW OF THE LITERATURE 
 
 
Healthy People 2010  established goals of having at least 90% of children aged 13-15 
years fully vaccinated with recommended and catch-up vaccines, and one of the new 
objectives of Healthy People 2020 seeks to increase routine vaccination coverage levels 
recommended by the ACIP for adolescents aged 13-17, including the influenza vaccine 
[25]. Recent additions of human papillomavirus (HPV), tetantus toxoid-reduced 
diphtheria toxoid-acellular pertussis, and meningococcal conjugate vaccines to the 
adolescent vaccination schedule has renewed interest in understanding how to improve 
vaccination rates among adolescents [17]. Although some studies have described 
aggregate influenza vaccination rates that include adolescents, very few studies 
specifically focus predictors for vaccination on this specific age group.  
 Influenza-associated pediatric mortality, which includes the adolescent 
population, became a nationally notifiable condition in 2004 after a severe 2003-2004 
influenza season [11]. Improved understanding of the factors which influence influenza 
vaccination in the adolescent age group is also an imperative public health goal as the 
recent 2009 A/H1N1 pandemic has highlighted the weaknesses and strengths of modern 
global pandemic preparedness and changed the manner in which the world responds to 
future pandemics [26]. The pandemic surprised the world in April 2009 by initiating in 
Mexico and the U.S., and has also presented challenges because plans to control 
pandemics had not been calibrated for a pandemic of milder disease [26]. 
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Epidemiological tools and prediction models had suggested that an influenza pandemic 
would likely start from Asia and spread westward towards Europe, Africa, and the 
America [26].  
 
The purpose of this study is to analyze the association between influenza 
vaccination status in adolescents aged 13 to 17 and socio-demographic characteristics and 
household-reported health status based on data from 2008 National Immunization 
Survey- Teen. Socio-demographic characteristics include age, sex, race and ethnicity, 
region of the U.S., number of children under the age of 18 in household, health insurance 
status, and poverty status. Household-reported health status included whether the teen 
had asthma, whether the teen had any other underlying health conditions (including 
diabetes, heart conditions, and weakened immune system, etc.), and the number of 
missed school days due to illness or injury. Maternal socio-demographic characteristics 
include mother’s age, education level, and marital status.  
2.1 Virology 
Influenza viruses are negative-stranded RNA viruses in the Orthomyxoviridae family 
and divided into three majors types: A, B, and C [16]. The three virus types vary in 
pathogenicity and host range [8]. Influenza A viruses affect warm-blooded animals, 
including birds, swine, horses, humans, and other mammals, and are further characterized 
into sixteen hemagglutinin and nine neuraminidase subtypes [8]. Influenza A viral 
replication peaks approximately 48 hours after inoculation into the nasopharynx, and the 
viruses replicate in both the upper and lower respiratory tract [8].  Novel influenza virus 
variants result from frequent antigenic change caused by point mutations (antigenic drift) 
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and recombination events (antigenic shift) that occur during viral replication. As a result,  
new influenza A subtypes have the potential to cause a pandemic when they are able to 
cause human illness and demonstrated efficient human-to-human transmission and when 
little or no previously existing immunity has been identified [1].  
Influenza B viruses infect a smaller number of species, namely humans and seals, 
and recent circulating influenza B viruses are separated in the Yamagata or Victoria 
genetic lineages [8, 13].   Influenza B viruses undergo antigen drift less rapidly than 
influenza A viruses and do not cause pandemics [8, 13]. Influenza C viruses are endemic 
and sporadically cause mild respiratory disease [8].   
2.2. Clinical Course and Epidemiology  
Symptoms of influenza infection include onset of high fever, coryza, cough, 
headache, prostration, and inflammation of the respiratory tree and trachea [8]. Acute 
symptoms and fever often persist for 7 to 10 days, and severe complications from 
influenza infection could include hemorrhagic bronchitis, pneumonia, and death [8]. 
Prevalence of infection is greatest in school-age children while disease severity is greatest 
in the elderly, infants, and those with underlying health conditions including chronic 
pulmonary or cardiac disease, and diabetes [8].  Diagnosis of influenza infection can be 
made by virus isolation, detection of viral proteins, and  detection of viral nucleic acid 
using nasopharyngeal or throat swabs as well serological assays which detect antibodies 
to the influenza virus [1]. 
Influenza outbreaks have occurred since the Middle Ages and there have been 
approximately a dozen influenza A virus pandemics since 1700 [8].  The pandemic of 
1918 caused approximately 546,000 excess deaths and killed up to 50 million people 
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worldwide [27-28].  Annual influenza epidemics in the United States usually occur in the 
fall or winter months but the peak of influenza activity can occur as late as April or May 
[13].  Influenza activity during the 2009 H1N1 pandemic peaked in June during the first 
wave and mid-October during the second wave [29]. The second wave was also 
associated with higher pediatric mortality and higher rates of hospitalization in children 
and young adults than in previous five seasons [29].   
2.3 Vaccine History  
Annual influenza vaccination remains the primary and most effective method of 
preventing influenza infection and decreasing viral transmission within a community 
[13].  It is also highly cost effective and even cost saving among the elderly, and may be 
cost effective for young children and adults [30]. The Armed Forces Commission on 
influenza was responsible for the development and evaluation of influenza vaccines in 
order to prevent outbreaks of influenza illness in the US military during the Second 
World War [31].  Regular evaluations of aqueous whole-virus inactivated vaccines 
containing prevalent strains as well as evaluation of various innovative vaccines 
continued from 1943 to 1969, but the use of whole viruses in vaccines ended with the 
introduction of split or subunit preparation [31].  
The vaccine had been efficacious in preventing infections by viruses similar to those 
included in the vaccine, but in 1947, antigenic drift caused the vaccine’s efficacy to drop 
[32].. After 1977, trivalent vaccines containing 2 representative influenza A subtypes and 
a representative B type have been used [33]. Although purity, potency and 
standardization of the vaccine has improved, major challenges with the trivalent vaccine 
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included limited breadth of immunity, short duration of protection, needle inoculation, 
lower protection induced in older individuals, and dependence on egg supply [31]. 
2.4 Vaccination Types and Recommendations  
After the introduction of influenza vaccines for limited use in the military in the 
1940s,  indications for vaccine use gradually increased [34]. The Advisory Committee on 
Immunization Practice (ACIP) has now recommended a universal influenza 
immunization policy for seasonal influenza vaccine for all persons aged 6 months and 
older for the 2010-2011 influenza season [13]. Children aged 6 months to 8 years are 
recommended to receive 2 doses of the 2010-2011 influenza vaccine 4 or more weeks 
apart unless 1) they have received either 1 dose of the 2009 H1N1 vaccine last flu season 
and 2) at least 1 dose of seasonal vaccine prior to the 2009-2010 influenza season or 2 
doses of 2009-10 seasonal flu vaccine last flu season [35]. If a child has fulfilled both 
requirements, only 1 dose of the vaccine is needed [35]. All other individuals aged 9 and 
older receive only 1 dose. 
 Prior to the universal recommendation, there have been over 20 indications where 
influenza immunization was recommended [34].  Health care professionals, pregnant 
women, immunocompromised individuals, and those with chronic heart or pulmonary 
disease are special populations which the ACIP targets influenza immunization [13]. In 
addition, because children younger than 6 months cannot get a vaccine or antiviral drugs, 
but are at high risk for serious flu-related complications, the ACIP recommends the 
vaccine for caregivers and household contacts of children less than 6 months old, children 
younger than 5 years old, and adults aged ≥50 years old [13, 29]. The ACIP first 
recommended annual influenza vaccination of health care workers to reduce nosocomial 
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transmission of influenza to patients at high risk for infection in 1986 [36]. Healthy 
children less than 2 years of age had not been included in recommendation for routine 
influenza vaccination until the 2002-2003 season [37].  Finally, in 2008 ACIP expanded 
their recommendation to include not only persons aged 50 and over, 18-49 years at higher 
risk for influenza complications, and 6 months to 4 years of age, but also all children 
aged 5-18 for the 2008-2009 influenza season [38].  
Currently, the two types of vaccine available are the trivalent inactivated vaccine 
(TIV) administered by intramuscular infection and the live attenuated (LAIV) 
administered by intranasal spray.  Whereas TIV contains inactivated viruses and cannot 
cause influenza, LAIV contains live attenuated influenza viruses that have the potential to 
cause mild signs or symptoms related to vaccine virus infection [13]. Currently, both 
contain two types of influenza A (H1N1 and H3N2) and one B-strain, and have been 
proven to be safe and effective [39]. TIV is licensed for use among person aged 6 months 
and older for those with chronic medical conditions and those who are healthy, but LAIV 
is only licensed for use among non-pregnant persons aged 2-49 years [13]. Safety or 
effectiveness of LAIV has not been established in persons with underlying medical 
conditions that confer a higher risk for influenza complications [13].  
TIV is contraindicated to persons who have anaphylactic hypersensitivity to eggs or 
to other components of the influenza vaccine, and prophylactic use of antiviral agents is 
an option for preventing influenza among such persons [13]. Persons with moderate or 
severe acute illness with or without fever is a precaution for TIV and Guillain-Barré 
Syndrome within 6 weeks following a previous dose of influenza vaccine is considered to 
be a precaution for use of influenza vaccine [13].  
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2.5 Vaccination Supply and Coverage  
The annual supply of influenza vaccine and the timing of its distribution cannot be 
guaranteed in any year, and distribution delays or vaccine shortages remain possible [13]. 
The U.S. has experienced disruptions in the manufacture or distribution of inactivated 
influenza vaccine in 4 seasons during the last decade [40-41]. If supplies of season 
influenza vaccine are not adequate, vaccination is carried out in accordance with local 
circumstances of supply and demand based on the judgment of state and local health 
officials and health-care providers [13]. Multiple manufacturing and regulatory issues, 
and inherent critical time constraints in manufacturing the vaccine given the annual 
updating of influenza vaccine strains may affect production [13]. During shortages of 
TIV, LAIV is recommended when feasible for all healthy non-pregnant persons aged 2-
49 who desire or are recommended for vaccination in order to increase the availability of 
inactivated vaccine for persons at high risk [13].  
The Centers for Disease Control and Prevention (CDC) routinely monitors influenza 
vaccination coverage levels using Behavioral Risk Factor Surveillance System (BRFSS), 
the National  Immunization Survey (NIS), the National Health Interview Survey (NHIS), 
and eight sentinel immunization information system (IIS) sites located in the United 
States [38]. Specifically, the NIS was established to fulfill the 1992 Childhood 
Immunization Initiative (CII) mandate of monitoring vaccination coverage and progress 
towards achieving the Healthy People 2010 objective of having at least 90 percent of 
children aged 13-15 years fully vaccination with recommended and catch-up vaccines 
[42]  
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Influenza vaccine coverage in all recommended groups remains suboptimal and 
below Healthy People 2010 objectives [13]. Recent NHIS estimates of vaccine coverage 
levels among adults with high-risk conditions aged 18-49 years were 30.4% in the 2007-
08 season and 33% in the 2008-09 season [13]. Among adults with asthmas aged 18-49 
years and 50-64 years, approximately 24% and 55%, respectively received the 
vaccination [13]. Vaccination levels are reportedly not only low among children at 
increased risk for influenza complications but also decline with increasing age [13]. 
Coverage among children with asthma aged 2-17 years was approximately 29% for the 
2004-05 influenza season [43]. Data from the eight IIS sentinel sites also revealed that 
coverage was 29% among children aged 6-23 months, 22% among children 2-4 years, 
and 9% among children aged 13-18 years [44].  
2.6 Vaccination Predictors 
Although many studies have investigated predictors associated with influenza vaccine 
coverage among high-risk or ACIP recommended groups, few studies have examined 
predictors among healthy adults [45]. Among the ACIP recommended or high-risk 
groups, perceived doctor’s recommendations, belief that getting the influenza vaccine is a 
“smart idea”, concern about vaccine side-effects, and perception that the vaccine was not 
needed have been found to be predictors of influenza vaccination [46-47]. The available 
studies among healthy adults reveal that predictors of vaccine acceptance are similar to 
those of high-risk patient population and health care workers [48].  
Few studies have also examined the influence of socioeconomic and demographic 
factors and influenza vaccination.  Results of a few studies have suggested that parental 
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education status, gender, household income, and size of household may significantly 
contribute to chances of getting immunized [2, 45]. 
Reducing racial and ethnic disparities in influenza coverage also presents a national 
public health challenge [13]. Although adult influenza vaccination levels have increased 
in the past decade, recent studies continue to document racial and ethnic differences in 
vaccination coverage [49]. Vaccination coverage levels in 2008 among person aged 65 
and over were 70% for non-Hispanic whites, 52% for non-Hispanic blacks, and 52% for 
Hispanics [13]. In a study among nursing home patients, fewer blacks and Hispanics 
were offered vaccine or received it compared with whites, and blacks refused vaccination 
more frequently [50].   
2.7 Influenza, Vaccinations, and Adolescents   
Influenza vaccine may be comparatively more effective among children and 
adolescents and 
studies have demonstrated a definite advantage over influenza vaccination in this age 
group [22]. Unfortunately, studies have found that missed opportunities, lack of 
population-based immunization registries that include adolescents, low public and peer 
awareness about immunization covered in this age group, misperceptions about vaccine 
safety, and lack of knowledge about the importance of vaccinations all contribute to low 
immunization rates [51]. Although healthy adolescents are not a high-risk group for 
severe influenza infection, they still may act as vectors for transmitting disease to 
contacts and family members considered high risk [22]. In addition, with the emergence 
of new influenza strains, patterns of disease severity diverging from previous experiences 
have been observed [22]. For example, cases of adolescents and young adults suffering 
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severe H1N1 influenza have been reported much more frequently [22]. With the increase 
in bacteria co-infections seen in the older pediatric population, reducing the risk of 
influenza infection could also presumably reduce the invasive bacterial infections that are 
facilitated by disruptions in host defenses during influenza virus infection [11]. 
Summary  
Influenza vaccines are among the oldest of successful vaccines that are still in use 
and deficiencies are being addressed by a number of innovative approaches in vaccine 
development [31]. Despite the burden of influenza infection and universal vaccination 
recommendation, studies have suggested that coverage in all groups remain low [13]. 
Additional research should be done to investigate opportunities how to improve coverage 
as well as education to both health care providers and general public.  
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Chapter III 
METHODOLOGY 
3.1 Data Source 
The data used in this study were obtained from the 2008 National Immunization 
Survey (NIS) Teen, a publicly available database that contains de-identified information. 
The NIS is sponsored by the National Center for Immunizations and Respiratory Diseases 
(NCIRD) and is conducted jointly with the National Center for Health Statistics (NCHS) 
of the Centers for Disease Control and Prevention.  Established as part of the Childhood 
Immunization Initiative by President Clinton, the NIS is a list-assisted, random-digit-
dialing telephone survey followed by a mailed survey to participants’ immunization 
providers. Telephones numbers are drawn independently, for each quarter, within 
selected geographical areas. The survey began data collection in April 1994 to monitor 
childhood immunization coverage and is repeated annually.   
NIS is targeted to children ages 19-35 months living in the United States at the 
time of the interview and the data collected are used to produce estimates of vaccination 
coverage rates for all childhood vaccinations recommended by the ACIP. However, to 
assist in measuring progress towards the Healthy People 2010 objectives for teens, the 
NIS-Teen was developed and conducted for the first time in 2006 as an expansion of NIS.  
If a household with a 19-35 month old child is identified and the NIS interview is 
completed, the household is then screened for the presence of any13-17 year old children. 
Households that do not have a 19-35 month old child are immediately screened for the 
presence of 13-17 year-old children. If a household contains one or more children aged 
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13-17, a teen is randomly chosen and the adult who is most knowledgeable about the 
teen’s vaccinations is interviewed. With the consent of the teen’s parents or guardian, 
NIS-Teen also follow-up via mail with the teen’s health care provider(s) to request 
information on the teen’s vaccination status from medical records.  Survey participation 
is voluntary and confidential.  
NIS provides data online in ASCII format and interested users are allowed to 
download the files into a variety of statistical software. Syntax files for SAS and R are 
provided on the NIS website. The 2008 NIS-Teen data files were downloaded from the 
NIS website and converted from a SAS7bdat file for Statistical Package for Social 
Sciences (SPSS) version 18.0. SPSS 18 was used for all analysis in this study.  
3.2 Study Population  
 The target population for NIS-Teen was children aged 13-17 living in non-
institutionalized households in the United States at the time of the interview.  Household 
interviews began January 3, 2008 and ended on February 4, 2009. All fifty states, 
including the District of Columbia, were surveyed. Findings from the surveys were 
released only in summary form. In this study, only data from the 2008 survey were 
available and utilized.  
3.3. Study Measures and Variables  
The primary dependent variable for this study was the teen’s receipt of influenza 
vaccination in the last 12 months based on the respondent’s recall. The January 2008 to 
February 2009 timeframe of the household interviews allows for the possibility that 
influenza vaccination status could be in response for the 2006-2007, 2007-2008, and 
2008-2009 influenza seasons.  
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The demographic independent variables for each household included: sex, age, 
race and ethnicity, region of U.S., and number of children under the age of 18 living in 
the household. The socioeconomic independent variables used in this study were poverty 
status and health insurance status. Poverty status was based on the 2007 Census poverty 
threshold of $14, 291 in a two person household with 1 child under the age of 18 [52] . 
Types of health insurance surveyed included: employer health insurance, Medicaid, S-
CHIP, Indian Health Services, Military/Tricare/CHAMPUS/CHAMP-VA, or other form 
of health insurance not named.   
The household-reported health status included whether or not the teen had been 
told by a health professional that he or she has asthma or an underlying health condition. 
Underlying conditions was defined by the NIS as having a lung condition other than 
asthma, a heart condition, a kidney condition, sickle cell anemia or other anemia, a 
weakened immune system caused by a chronic illness or by medicines taken for a chronic 
illness. These underlying health conditions are typically risk factors which may put 
individuals at higher risk for complications from influenza infection. The number of 
school days missed due to illness or injury was also collected. Maternal socio-
demographic characteristics included mother’s age, education level, and the marital 
status. 
Variables that were taken directly as coded from the original data set were: age, 
race and ethnicity, region of U.S., asthma status, and underlying health condition. Race 
and ethnicity was coded as non-Hispanic white, non-Hispanic black, non-Hispanic other 
race and multirace. Hispanic or Latino included those who identified the teens as 
Mexican, Mexican-American, Central American, South American or Puerto Rican, 
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Cuban, or other Spanish- Caribbean. Non-Hispanic other race or multirace included 
Native American, Alaskan native, Asian, Native Hawaiian, Pacific Islanders, and those 
who identified the teens as “Other.”  Other variables that were used as coded in the 
original data set included the number of children under 18 in the household, poverty 
status, and the maternal socio-demographic characteristics. Poverty status was re-
categorized by NIS into the follow three groups: above poverty and > $75k, above 
poverty <= $75k, and below poverty.  Mother’s age was grouped into 34 years of age and 
younger, 35-44 years, and 45 years of age and older. Mother’s education level was 
grouped into the following: less than 12 years, 12 years, more than 12 years but non-
college graduate, and college graduate. Mother’s marital status was grouped into 
widowed/divorced/separated, never married, and married.  
The following variables were re-categorized in the current analysis: health 
insurance and days of school missed. Health insurance status was re-categorized to a 
dichotomous variable that was zero if the teen reported no insurance and one if the teen 
was covered by one or more form of the following health insurance plans listed above. 
The number of missed school days by teen due to illness or injury was re-categorized into 
the following: 0, 1 to 9 days, 10-19 days, 20-29 days, and 30 or more.  
3.4 Statistical Analysis 
Descriptive statistics were created to describe the population sample. An odds 
ratio calculation was performed to analyze any association between receipt of influenza 
vaccination and socio-demographic characteristics and household-reported health status. 
Using a binary logistic regression analysis, odds ratios were calculated along with 95% 
confidence intervals and p-value. A p-value of < 0.05 was considered a statistically 
19 
 
significant association between the socio-demographic factors, household-reported health 
status, with receipt of the vaccine.  
To further examine potential associations between the dependent and independent 
variables, multivariate logistic regression analysis was performed for influenza vaccine 
receipt where all socio-demographic characteristics and household-reported health status 
variables were considered at once. Odds ratios were calculated, along with 95% 
confidence intervals and variables were considered significantly associated with receipt 
of the influenza vaccine at the aforementioned accepted p-value of < 0.05. 
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Chapter IV 
RESULTS 
 
4.1 Frequencies and Descriptive Statistics 
Frequencies and descriptive statistics about the study sample are detailed in 
Tables 1 through 6. The sample size for this study included 29063 adolescents where 
19.8% of the respondents reported receiving the influenza vaccine (Table 1). A total of 
1,618 respondents who reported not knowing the influenza vaccination status, refused to 
respond, or had a missing response and were excluded from this analysis.  
In this study population, 51.9% were male and 48% were female.  Limited data 
were available for influenza vaccine type, month of vaccination, and place of vaccination. 
These results are presented in Tables 1 and 2. 
Of the five age categories, the 16 year old age group was the most represented 
category with 21.4% of the respondents. Non-Hispanic whites were the most represented 
race/ethnicity among the study population (68.6%) and non-Hispanic other race and 
multirace were the least represented race/ethnicity (7.1%).  More than one third (36.4%) 
of the study population resided in the South, and approximately one half of the teens 
(50.9%) lived in households with 2 or 3 children under the age of 18.  
Of those surveyed where information on income and health insurance status was 
obtained, almost half (46.6%) of the study population reported annual family income 
above the 2007 U.S. Census Bureau poverty threshold and less than or equal to $75,000, 
and 93.3% reported having one or more form of health insurance. Nonresponse as a result 
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of refusal to answer, lack of knowledge, or dropped interview resulted in 6 percent of the 
poverty status and 20 percent of the health insurance unavailable for analysis. The results 
are presented in Table 4.  
Of those surveyed where the teen’s household-reported health status was 
available, 18.1% reported having been told by a health professional that the teen had 
asthma, and 5.8% reported having been told he or she has an underlying health condition. 
The results are presented in Table 5.  
 
Table 1. Influenza Vaccine Receipt Data 
Vaccine Receipt N (%) 
Yes 5752 (19.8) 
No 23311 (80.2) 
 29063 
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Table 2. Influenza Vaccine Descriptive Data by Type, Place, and Month of Vaccination 
 
Vaccine Type N (%) 
Shot 5184 (94.1) 
Spray/Mist 324 (5.9) 
 5508 
Place of Vaccination  N (%) 
Doctor’s Office 3330 (58.1) 
Health Department 331 (5.8) 
Clinic 1087 (19.0) 
Hospital 235 (4.1) 
Other Medical Facility  102 (1.8) 
Pharmacy 169 (2.9) 
Work 65 (1.1) 
Other Non-Medical Place 417 (7.3) 
 5736 
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Table 2. Influenza Vaccine Descriptive Data by Type, Place, and Month of Vaccination Cont’d  
 
Month N (%) 
January 194 (3.7) 
February 118 (2.2) 
March 52 (1) 
April 30 (0.5) 
May 30 (0.5) 
June 20 (0.4) 
July 23(0.4) 
August 123 (2.3) 
September 412 (7.9) 
October  2088 (40.0) 
November 1709 (32.8) 
December 411 (7.9) 
 5210 
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Table 3. Demographic Characteristics and Vaccination Status of NIS Teen 2008 Influenza 
Vaccination Study Population  
 
Demographic 
Characteristic 
N (%) No. Vaccinated (%) 
   
Sex   
      Male 15111 (51.9) 2867 (19.0) 
     Female 13952 (48.0) 2885 (20.7) 
Total 29063  
   
Age    
     13 5395 (18.6) 1147 (21.2) 
     14 5850 (20.1) 1250 (21.3) 
     15 5953 (20.4) 1173 (19.7) 
     16 6212 (21.4) 1170 (18.8) 
     17 5633 (19.4)  1012 (18.0) 
Total 29063  
   
Race and Ethnicity   
     Non-Hispanic White  19946 (68.6) 3579 (17.9) 
     Hispanic 3516 (12.1) 777 (22.1) 
     Non-Hispanic Black 3535 (12.2) 831 (23.5) 
     Non-Hispanic Other   
&  Multirace 
2066 (7.1) 565 (27.3) 
Total 29063  
   
Region of U.S.   
   Northeast  5469 (18.8) 1099 (20.1) 
   Midwest 6823 (23.5) 1240 (18.2) 
   South 10571 (36.4) 2214 (20.9) 
   West 6200 (21.3) 1199 (19.3) 
Total 29063  
   
No. of Children < 18 in 
Household 
  
       1 11594 (39.9) 2204 (19.0) 
       2 or 3 14796 (50.9) 2978 (20.0) 
       4 or more 2673 (9.2) 570 (21.3) 
Total 29063  
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Table 4. Socioeconomic Characteristics and Vaccination Status of NIS Teen 2008 Influenza 
Vaccination Study Population  
 
Socio-demographic 
Characteristics 
N (%) No. Vaccinated (%) 
Poverty Status   
   Above  Poverty >75k  11044 (38.0) 2292 (20.8)  
   Above Poverty <=75k 12679 (43.6) 2296 (18.1) 
    Below Poverty 3471 (11.9) 807 (23.0) 
    Missing/Don’t  
know/Refused 
1869 (6.4)   
Total 29063 5395 
   
Health Insurance 
Status 
  
    Insured  21773 (74.9) 4361 (20.0) 
    Not Insured 1553 (5.3) 217 (14.0) 
  Missing/Don’t 
Know/Refused 
5954 (20.5)  
Total 29063 4587 
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Table 5. Household-reported Health Status and Vaccination Status of NIS Teen 2008 Influenza 
Vaccination Study Population  
 
Household-reported Health 
Status 
N (%) No. Vaccinated 
   
Has been told he/she has 
asthma 
  
    Yes  5286 (18.2) 1572(29.7) 
     No 23736 (81.7)  4167 (17.6) 
Missing/Don’t Know/Refused 41 (0.14)  
Total 29063  
   
Has ever been told he/she had 
underlying health 
condition?*  
  
    Yes 1688 (5.8) 528 (31.2) 
     No 27347 (94.1) 5216 (19.1) 
Missing/Don’t Know/Refused 28 (0.1)  
Total 29063  
   
No. of Missed School Days 
because of Illness or Injury 
  
0 8212 (28.3) 1544 (18.8) 
1 to 9 18033 (62.0) 3491 (19.4) 
10-19 1862 (6.4) 446 (24.0)  
20-29 337 (1.2)  92 (27.3) 
30 or more 342 (1.2) 95 (27.8) 
Missing/Unknown/Refused/Did 
not go to school 
277 (0.95)  
Total 29063  
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Table 6.  Maternal Socio-demographic Characteristics and Vaccination Status of NIS Teen 2008 
Influenza Vaccination Study Population  
 
Maternal Socio-demographic 
Characteristics 
N No. Vaccinated (%) 
   
Mother’s Age   
    <=34 yrs 2342 (8.1) 546 (23.3) 
    35-44 yrs 13157 (45.3)  2538 (19.3) 
    >=45 yrs 13564 (46.7) 2688 (19.8) 
Total 29063  
   
Mother’s Education Level   
      < 12 yrs 2879 (10.0) 614 (21.3) 
      12 years 6336 (21.8) 1174 (18.5) 
     >12 years, Non-college graduate 8907 (30.6)  1684 (18.9) 
      College graduate  10941 (37.6) 2280 (20.8) 
Total 29063  
   
Mother’s Marital Status     
    Widowed/Divorced/Separated 5099 (17.5) 1013 (19.9) 
    Never Married 2027 (7.0) 497 (24.5) 
    Married 21937 (75.5) 4242 (19.3) 
Total 29063  
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 With regards to maternal socio-demographic characteristics, teens with mothers in 
the 45 and older age group were the most represented (46%) whereas only 8.1% of teens 
with mothers were in the 34 and younger age group. More than one third (36.7%) of the 
respondents reported that the teen’s mother was a college graduate, and approximately 
three quarters (75.5%) reported that the teen’s mother was married.  
 Frequency and prevalence of influenza vaccination are also detailed in Tables 3 
through 6.  Females, 14 year olds, non-Hispanic other race and multirace, the southern 
region of the U.S., and households with four or more children under 18 years of age had 
the highest prevalence of vaccination in the study population. Descriptive results revealed 
that 20% of the female adolescents were vaccinated compared with 19% of males. 
Approximately 21% of 14 year old teens in this study reported receiving the vaccination. 
Approximately 27 % of teens in the non-Hispanic other race and multirace category 
reported receiving the influenza vaccine, where as only 17.9% of the non-Hispanic white 
teens reported receiving the influenza vaccine.  Teens who resided in the Southern region 
of the U.S. reported the highest prevalence of vaccination at 20.9% whereas teens who 
resided in the Midwest reported a prevalence of only 18%. Finally, 21% of teens in the 
survey who resided in households with 4 or more children under the age of 18 were 
vaccinated.   
With regards to socioeconomic factors, teens with one or more form of health 
insurance, and teens who reported living below poverty had highest prevalence of 
influenza vaccination. With regards to household-reported health status, teens who 
reported having asthma and underlying health conditions, and those who reported missing 
30 or more days of school due to illness or injury all reported having the highest 
29 
 
prevalence of vaccination. Teens whose mothers were in the 45 years of age and older 
age group, mothers who had less than 12 years of education, and mothers who never 
married were found to have the highest prevalence of influenza vaccination in the study 
population.   
4.2. Demographic characteristics   
Bivariate analysis using logistic regression assessed the association of 
demographic characteristics with the receipt of influenza vaccine. The results are shown 
in Table 7. With regards to sex, females were 1.11 times more likely to receive the 
vaccine compared with males. Age also played a significant role in the odds of receiving 
the vaccine where a one year increase in age resulted in a slight decrease (OR=0.94) in 
the odds of vaccination (p< 0.001). Those who were identified themselves as non-
Hispanic other race and multi-race teens were the most likely to have received the 
influenza vaccine compared to non-Hispanic whites (OR=1.72). When region of the U.S. 
was analyzed, the only subcategory found to be statistically significant was the Midwest 
(OR=0.88, p=0.007). Teens who lived in households which had four or more children 
under 18 were 1.16 times more likely to receive the vaccine as compared to those who 
had only one child under the age of 18 (p=0.006).  
Additional analysis of the demographic factors influencing influenza vaccine 
receipt was performed by including all of the independent variables in a multivariate 
logistic regression model. Results are presented in Table 11. Both sex and race/ethnicity 
remained statistically significant. Females 1.15 times more likely to receive the vaccine 
than males and non-Hispanic other race & multirace teens were 1.71 times more likely to 
receive the vaccine compared with the non-Hispanic white referent group. Age also 
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remained statistically significant where a one year increase in age resulted in a slight 
decrease in odds of vaccination (OR=0.95,p< 0.001).  Region of U.S., and number of 
children under 18 in the household were no longer statistically significant in the 
multivariate model. 
Table 7.  Bivariate Analysis Using Logistic Regression Assessing the Association of Demographic 
Characteristics in NIS Teen 2008 Influenza Vaccination Study Population  
 
Variable OR CI p-value  
    
Sex    
      Male REF REF REF 
     Female 1.11 1.05-1.18 <0.001 
    
Age 0.94 0.92-0.96 <0.001 
    
Race and Ethnicity    
     Non-Hispanic White  REF REF REF 
     Hispanic 1.30 1.19-1.42 <0.001 
     Non-Hispanic Black 1.41 1.29-1.53 <0.001 
     Non-Hispanic Other   
&  Multirace 
1.72 1.55-1/91 <0.001 
    
Region of U.S.    
   Northeast  REF REF REF 
   Midwest 0.88 0.81-0.97 0.007 
   South 1.05 0.97-1.14 0.21 
   West 0.95 0.87-1.05 0.31 
    
No. of Children < 18 in 
Household 
   
       1 REF REF REF 
       2 or 3 1.07 1.01-1.13 0.023 
       4 or more 1.16 1.04-1.28 0.006 
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4.3 Socioeconomic Characteristics  
Bivariate analysis using logistic regression assessed the association of 
socioeconomic characteristics with the receipt of influenza vaccine. The results are 
shown in Table 8. The analysis of both poverty status and health insurance status 
indicated that both were correlated with receipt of the influenza vaccine. Teens who 
lived below poverty were 1.16 times more likely while teens who lived above poverty 
but less than or equal to $75,000 were less likely (OR=0.86, p<0.001) to receive the 
influenza vaccine when compared with the referent group (teens who lived above 
poverty and more than $75,000).  Teens who had at least one form of health insurance 
were 1.54 times more likely to have received the vaccine compared to those who 
reported no health insurance.  
Additional analysis of the socioeconomic factors influencing influenza vaccine was 
performed by including all of the independent variables in a multivariate logistic 
regression model. Poverty status remained statistically significant, but only in the 
category of those who reported annual income above the poverty threshold but less than 
or equal to $75,000. Health insurance also remained a statistically significant predictor 
of influenza vaccination. (OR=1.54, p<0.001).  
Table 8.  Bivariate Analysis Using Logistic Regression Assessing the Association of Socioeconomic 
Characteristics in NIS Teen 2008 Influenza Vaccination Study Population  
 
Variable OR CI p-value 
Poverty Status    
   Above  Poverty >75k  REF REF REF 
   Above Poverty <=75k 0.84 0.79-0.90 <0.001 
    Below Poverty 1.16 1.06-1.27 0.002 
    
Health Insurance 1.54 1.33-1.79 <0.001 
 
4.4 Household-reported Health Status  
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Analysis of the teens’ household-reported health status indicated that teens who 
had asthma and other underlying health conditions, and missed more days of school were 
all more likely to receive the vaccine. All three independent variables measuring teen 
health status were significantly associated with receipt of influenza vaccine, and the 
results are presented in Table 9.  All three also remained statistically significant when 
included in the multivariate model but the strength of the associations were lower after 
adjustment for other factors.  
 4.5 Maternal Socio-demographic Characteristics  
Independent analysis of maternal socio-demographic characteristics indicated that all 
three independent variables were statistically associated with receipt of influenza vaccine. 
Teens whose mothers were in the 35-44 age group were the least likely (OR=0.79, 
p<0.001) to receive the influenza vaccine compared with the referent group (mothers 
aged 34 or younger). Teen whose mothers were in the 45 years and older age group were 
also less likely to receive the vaccine compared with the referent group (OR=0.81, 
p<<0.001). Teens whose mothers who completed high school only were the least likely 
(OR=0.84, p=0.002) to receive the vaccine compared with the referent group (less than 
12 years of school). Teens whose mothers who were never married were 1.31 times more 
likely to receive the vaccine compared with the widowed/divorced/separated referent 
group (p<0.001).  
After adjusting for other variables, the only significant maternal socio-demographic 
characteristics variable was maternal age. Similar to the results from the bivariate 
analysis, teens whose mothers were in 35-44 age group were the least likely to receive the 
influenza vaccine compared with the referent group (mothers aged 34 or younger).  
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Table 9.  Bivariate Analysis Using Logistic Regression Assessing the Association of Household-
reported Health Status in NIS Teen 2008 Influenza Vaccination Study Population 
 
Variable OR CI p-value 
    
Has been told teen has 
asthma 
1.99 1.86-2.13 <0.001 
    
Has ever been told teen had 
underlying health 
condition?* 
1.93 1.74-2.15 <0.001 
    
Still has the underlying 
health condition 
1.76 1.42-2.19 <0.001 
    
No. of Missed School Days by 
teen because of illness or 
injury 
   
    0 REF REF REF 
   1 to 9 1.04 0.98-1.11 0.288 
   10-19 1.36 1.21-1.53 <0.001 
   20-29 1.62 1.27-2.07 <0.001 
   30 or more 1.66 1.30- 2.12 <0.001 
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Table 10.  Bivariate Analysis Using Logistic Regression Assessing the Association of Maternal Socio-
demographic Characteristics in NIS Teen 2008 Influenza Vaccination Study Population  
  
Variable OR CI p-value 
    
Mother’s Age    
    <=34 yrs REF REF REF 
    35-44 yrs 0.79 0.71-0.87 <0.001 
    >=45 yrs 0.81 0.73-0.89 <0.001 
    
Mother’s Education Level    
      < 12 yrs REF REF REF 
      12 years 0.84 0.75-0.94 0.002 
     >12 years, Non-college 
graduate 
086 0.78-0.95 0.004 
      College graduate  0.97 0.88-1.07 0.57 
    
    
Mother’s Marital Status      
    
Widowed/Divorced/Separated 
REF REF REF 
    Never Married 1.31 1.16-1.48 <0.001 
    Married 0.97 0.90-1.04 0.39 
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Table 11. Multivariate Analysis Using Logistic Regression Assessing the Association of Socio-
demographic Characteristics in NIS Teen 2008 Influenza Vaccination Study Population  
 
Variable OR CI p-value  
    
Sex    
      Male REF REF REF 
     Female 1.15 1.07-1.23 <0.001 
    
Age 0.95 0.92-0.97 <0.001 
    
Race and Ethnicity    
     Nonhispanic White  REF REF REF 
     Hispanic 1.33 1.19-1.49 <0.001 
     Nonhispanic Black 1.29 1.14-1.44 <0.001 
     Nonhispanic Other   
&  Multirace 
1.71 1.51-1.93 <0.001 
    
Region of U.S.    
   Northeast  REF REF REF 
   Midwest 0.93 0.84-1.04 0.19 
   South 1.04 0.94-1.14 0.45 
   West 0.93 0.83-1.04 0.19 
    
No. of Children < 18 in 
Household 
   
       1 REF REF REF 
       2 or 3 1.07 0.99-1.16 0.08 
       4 or more 1.12 0.98-1.30 0.10 
    
Poverty Status    
   Above  Poverty >75k  REF REF REF 
   Above Poverty <=75k 0.80 0.74-0.87 <0.001 
   Below Poverty 0.96 0.84-1.09 0.55 
    
Health Insurance 1.50 1.27-1.75 <0.001 
    
Has been told teen has 
asthma 
1.90 1.75-2.06 <0.001 
    
Has ever been told teen 
had underlying health 
condition?* 
1.70 1.50-1.93 <0.001 
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Table 11. Multivariate Analysis Using Logistic Regression Assessing the Association of Socio-
demographic Characteristics in NIS Teen 2008 Influenza Vaccination Study Population Cont’d 
 
 
Variable OR CI p-value 
No. of Missed School Days by 
teen because of illness or 
injury 
   
    0 REF REF REF 
   1 to 9 1.03 0.95-1.12 0.44 
   10-19 1.31 1.14-1.51 <0.001 
   20-29 1.54 1.17-2.04 0.002 
   30 or more 1.47 1.11-1.95 0.007 
    
Mother’s Age    
    <=34 yrs REF REF REF 
    35-44 yrs 0.81 0.71-0.91 0.01 
    >=45 yrs 0.86 0.75-0.98 0.03 
    
Mother’s Education Level    
      < 12 yrs REF REF REF 
      12 years 0.92 0.81-1.05 0.23 
     >12 years, Non-college 
graduate 
0.96 0.84-1.10 0.54 
      College graduate  1.06 0.92-1.21 0.43 
    
Mother’s Marital Status      
    
Widowed/Divorced/Separated 
REF REF REF 
    Never Married 1.16 1.00-1.35 0.05 
    Married 0.99 0.90-1.09 0.83 
  
 
*Underlying health condition was defined as having a lung condition other than asthma, a heart 
condition, a kidney condition, sickle cell anemia or other anemia, a weakened immune system caused 
by a chronic illness or by medicines taken for a chronic illness.    
 
 
4.6 Significant Association 
Table 12 shows a summary of the statistically significant socio-demographic 
characteristics and household-reported health status based on the bivariate and 
multivariate analyses performed for this study.  
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Sex, age, race and ethnicity, residing in the Midwest region, poverty status, health 
insurance, having asthma, having an underlying health condition, higher number of 
missed school days, and mother’s age, mother’s education level, and mother’s marital 
status were found to be statistically significant with the receipt of vaccination using the 
bivariate logistic regression model. Sex, age, race and ethnicity, living above poverty but 
less than $75,000, health insurance, having asthma, having an underlying health 
condition, higher number of missed school days, and mother’s age were found to be 
statistically significantly with the receipt of vaccination using the multivariate logistic 
regression model.  
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Table 12.  Summary of Bivariate and Multivariate Analyses Statistically Significant Socio-
demographic Characteristics and Household-reported Health Status for NIS Teen 2008 Influenza 
Vaccination Study Population  
 
Variable Bivariate analysis p-value Multivariate analysis p-value 
Female <0.001 <0.001 
Age <0.001 <0.001 
Hispanic <0.001 <0.001 
Nonhispanic Black <0.001 <0.001 
Nonhispanic Other Race and 
Multirace 
<0.001 <0.001 
Midwest 0.007 0.19 
South 0.21 0.45 
West 0.31 0.19 
No. of children < 18: 2 or 3 0.023 0.08 
No. of children <18: 4+ 0.006 0.10 
Above Poverty<=$75k <0.001 <0.001 
Below Poverty <0.001 0.55 
Health Insurance <0.001 <0.001 
Asthma <0.001 <0.001 
Underlying Health Condition <0.001 <0.001 
No. of Missed School Days: 1-9 0.29 0.44 
No. of Missed School Days: 10-19 <0.001 <0.001 
No. of Missed School Days 20-29 <0.001 0.002 
No. of Missed School Days: 30+ <0.001 0.007 
Mother’s Age: 35-44 yrs <0.001 0.01 
Mother’s Age: >=45 yrs <0.001 0.03 
Mother’s Education Level: 12 yrs 0.002 0.23 
Mother’s Education Level: >12 yrs, 
Non-college graduate 
0.004 0.54 
Mother’s Education Level: College 
graduate 
0.57 0.43 
Mother’s Marital Status: Never 
Married 
<0.001 0.05 
Mother’s Marital Status: Married 0.39 0.83 
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Chapter V 
Discussion and Conclusion 
5.1 Discussion 
. High influenza vaccination coverage of school-aged children not only provides 
both direct and indirect protection to students, school staff, and the broader community, 
but it also reduces student and teacher absenteeism [14]. Studies have demonstrated that 
encouragement from health care professionals can lead to beneficial health practices and 
higher vaccination rates[45]. However, primary care visits would have to increase by 
more than two thirds to achieve high vaccine coverage of 5 to 18 year olds [14]. 
Physician case loads have been near capacity with previous influenza vaccination 
recommendations and relying solely on the primary care provider could exacerbate 
existing health care disparities [14]. In addition, reminder and recall systems and 
reducing missed opportunities have only had limited success in increasing vaccination 
rates and do not account for the population of teens who are uninsured or do not see the 
same health care professional each time [14]. Reminder systems also do not address the 
disparities among different socio-demographic characteristics or the time and cost parents 
must spend to vaccinate their children.   
The purpose of this work was to examine the association between specific socio-
demographic characteristics and household-reported health status with receipt of 
influenza vaccinations in teens. Studies on the characteristics that describe the vaccinated 
portion of the adolescent population will allow public health and health care professionals 
implement appropriate interventions aimed at improving adolescent vaccination rates. 
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Demographic Characteristics 
Sex  
 Results from the multivariate analysis in this study revealed that female teens 
were more likely than male teens to receive the influenza vaccination. Some studies of 
health services use among school-aged patients revealed no differences according to sex 
[17]. However, another study determined older adolescent female subjects had more 
overall visits, largely because of visits to obstetricians/gynecologists [17]. Obstetrician-
gynecologists are the first and most frequent point of contact for women who seek 
medical consultation for reproductive health and are primary caregivers for many non-
pregnant women who have little or no contact with the healthcare system [53].  It is also 
possible this study population had female teens who were pregnant during influenza 
season and thus were recommended to receive the vaccine. The statistical significance 
found in the analysis could also be due to a large sample size, and exact reasons for a 
higher likelihood of female teen influenza vaccination in this study population are 
unclear. Further research is needed to explore this association.  
 Age 
 Results from this multivariate analysis revealed that age was a statistically 
significant predictor with influenza vaccination in this study population. The lower 
vaccination coverage found in older adolescents may have resulted from greater parental 
or health care provider influence on younger adolescents regarding immunization [17]. 
For example, providers have reported that they are more likely to assess immunization 
status and to administer immunizations in younger adolescents [51]. It is also important 
to note that adolescents in the 13-17 age group, except those who had underlying health 
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conditions, had not been included in any of the ACIP influenza recommended groups 
until the 2008-2009 influenza season [38]. Given these findings as well as the change to 
a universal recommendation by ACIP  following the influenza A H1N1 pandemic of 
2009, further research is needed to explore the association of the age and influenza 
vaccination.  
 Race 
 Results from the multivariate analysis revealed race and ethnicity was a 
significant predictor of influenza vaccination. However, findings from this study 
differed from what has been reported previously in the literature and in general trends 
noted in many social determinant studies, where Whites typically have fewer health 
problems and tend to have better health and fewer disparities to overcome with regards 
to health [54]. Although they constituted less than 10 percent of the study population, 
teens in the non-Hispanic other race and multirace group were the most likely to receive 
the vaccine compared with non-Hispanic white teens. It is unclear whether the lower 
immunization rates in the non-Hispanic white teens might be a reflection of the poor 
overall coverage or whether having better health might have led to the false perceptions 
that influenza is a mild disease and therefore the vaccine is not needed.  It is also 
possible the higher likelihood of influenza vaccination seen in teens in the non-Hispanic 
other race and multirace category was a result of targeted immunization campaigns as a 
result of socioeconomic status or underlying health conditions. Further research is 
needed to assess the association between influenza vaccination and race and ethnicity, as 
well as any immunization interventions received among the different race and ethnic 
groups.  
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Region of the U.S.  
 Region of the U.S. did not reveal trends that could show an overall association 
between region and likelihood of influenza vaccination. Although review of the 
literature did not indicate whether any region perceived higher risk of infection, or were 
more or less likely to receive the influenza vaccination, an important point to consider is 
that an universal vaccination strategy may not work across all cities with the same level 
of effectiveness [55]. There is no clear explanation for the results found in this study and 
regions might have been a proxy for other factors which predict adolescent vaccination. 
It is also important to note the local and state public health departments differ in their 
capacity to administer vaccinations. Many public health clinics do not have adequate 
capacity to bill and recover the costs of immunizations, 24 states are unable to provide 
vaccines for underinsured children in the private sectors, and only 56% of public health 
department immunization clinics use tracking and recall system [14, 53, 56].  More 
appropriate variables for this examination may have been population size, urban versus 
rural area, or distance and travel time required to receive vaccinations.  
Number of children under 18 in household  
Although trends from the descriptive data and odds ratio from the bivariate analysis 
indicated that teens were more likely to receive the influenza vaccination as the number 
of children under 18 in the household increased, results from the multivariate model 
revealed that after adjusting for other variables, the number of children was not a 
statistically significant predictor for receipt of influenza vaccination. Previous research 
has revealed mixed findings with household size and immunization coverage. One study 
of Latino and African-American preschool aged children suggested that an increase in the 
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number of preschool aged children in the household resulted in lower likelihood of 
receiving childhood immunizations with [57]. A European study on socioeconomic 
determinants and influenza vaccination found that person living in two persons 
households were more likely to be vaccinated but living in a household with three or 
more persons had a negative effect on the vaccination rate [2]. The number of children 
could be a proxy for other factors and further studies should analyze the impact of both 
age group and number of children and persons in the household. It is possible that a more 
appropriate variable could have been one which stratified the age groups of children in 
the household as literature has shown that office visits for preventive and episodic care 
are less frequent for school-aged children than for infants and preschool children [14].   
Socioeconomic Characteristics  
Poverty Status   
Results from this analysis revealed that after adjusting for other variables, poverty 
status was only a statistically significant for receipt of influenza vaccination for teens 
who reported living above poverty but less than or equal to $75,000. Teens who lived 
above poverty but reported annual household income of less than $75,000 were less 
likely than teens in the referent group (above poverty but reported an annual household 
income of more than $75,000) to receive in the influenza vaccine.  Although teens who 
lived below poverty were also found to be less likely to receive the influenza vaccine 
compared with the referent group, this association was not statistically significant. 
Although cost is not a barrier for vaccinations for the majority of children in the U.S. 
[56],  the findings from this study are consistent with previous findings that lower income 
levels contribute to the inability of obtaining health insurance, and the cost to families is a 
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barrier to the delivery of immunization [58]. Costs to vaccinate can also exist in the form 
of the lost time and cost of transportation, which disproportionately affects low-income 
parents, required to vaccine [14]. These results also suggests that teens who lived above 
poverty but less than $75,000 may not have qualified for government funded healthcare 
and benefits though they were also not financially stable enough to afford the vaccine. 
Further research should investigate the association between household income and 
influenza vaccination, as well as assess the expense to receive vaccines, including lost 
time and transportation costs, for families.  
Health Insurance Status 
Results from this analysis revealed that after adjusting for other variables, having one 
or more form of health insurance was a statistically significant predictor for receipt of 
influenza vaccine. These results support the hypothesis that an important barrier to 
preventive health services such as influenza vaccination is the lack of access to care. 
Most health insurance plans cover the costs of vaccination and the federal government 
provides free vaccines through the Vaccines for Children (VFC) program [56]. However, 
similar to the findings from the poverty status variable, there remains a population of 
children and young adults who may neither be covered by health insurance nor eligible to 
receive free VFC vaccines. Approximately 11% of young children and 21% of 
adolescents fall outside the care of private health insurance and government programs 
[56]. In addition, even with the assistance of the VFC program, families may need to pay 
a moderate VFC administrative fee in order to receive the vaccine [58]. It should be 
noted, however, that health insurance status was not available on approximately 20% of 
the study population and further research is needed in order to better address the 
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association between health insurance and influenza vaccination. Evaluation of the type of 
health insurance (private, public, military etc,) and if the teen’s insurance had covered the 
cost of the vaccine are also important components to consider. 
Household-reported Health Status  
Asthma  
 Results from the analysis revealed that having asthma was a statistically 
significant predictor for receipt of influenza vaccination. Individuals with asthma are at 
increased risk of complications from influenza infection, and the vaccination of adults 
and children with asthma has been recommended for many years [41]. These findings are 
consistent with previous research which has discussed the association between asthma 
status and influenza vaccine status. These findings may reflect better knowledge of 
vaccination recommendations or they also may reflect having access to care and 
providers who would remind the families about vaccinations [17]. It is important to note 
that the percentage of asthmatic teens who receive the influenza vaccine can still be 
improved. Healthy People 2010 National Objectives aimed for influenza vaccination of at 
least 60% of adults aged 18-64 with asthma and other underlying health conditions, but 
studies have shown that vaccination coverage among adults with asthma is low [41]. 
Although the teens in this study were not part of that particular Healthy People 2010 
objective’s age group or risk group, it is important for both public health professionals 
and health care providers to keep in mind when developing intervention strategies that 
adolescents will soon enter that recommended age-risk group, and that perhaps 
intervention targeting adolescents or even younger children may help with vaccination 
coverage for reaching Healthy People 2020 objectives. Further research should seek to 
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survey the role of physician recommendations, recall/reminder systems, and influenza 
vaccination in the asthmatic teen population. The severity of asthma in teens should also 
be assessed as one study has suggested low vaccination rates might be attributed to 
providers who may not remember to vaccinate patients with milder asthma against 
influenza [17].  
 Underlying Health Conditions 
Results from the analysis revealed that having been told by a health professional 
that he or she had one of the underlying health conditions surveyed was a statistically 
significant predictor for receipt of influenza vaccination. Similar to findings of the 
asthma status, these findings may reflect better knowledge of vaccination 
recommendations or they also may reflect already requiring or having access to care [17]. 
It is also possible that teens who reported having underlying health conditions were under 
the care of medical specialists or enrolled in health care maintenance organizations with 
successful immunization strategies which remind teens and their families with 
vaccination updates. For example, one study has found that diagnosis-based billing data 
accurately identified children who had high risk health conditions and needed annual 
influenza vaccination, and registry-driven reminders/calls significantly increased 
influenza immunization in targeted children [59]. The NIS-Teen only assessed whether 
the teen had underlying health conditions but did not ask respondents to identify the 
specific health conditions. Further research should seek to identify which specific health 
conditions (lung diseases versus heart conditions) are more likely to be strong predictors 
for receipt of influenza vaccine. The availability of any vaccine recall/reminder program 
in place should also be assessed.  
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Number of Missed School Days Due to Illness or Injury 
Results from the analysis revealed all subcategories of number of missed school 
days, except for 1-9 days, were statistically significant predictors for receipt of influenza 
vaccination in this study population. Teens who missed thirty of more school days were 
the most likely to receive the influenza vaccination more school days were more likely to 
receive the influenza vaccine when compared with teens who did not miss any days of 
school. Although the literature has shown that vaccination can reduce student and teacher 
absenteeism, and that that influenza-like illness increases the economic burden among 
households with school-aged children and leads to more lost school [60], data on the 
number of missed school days due to illness or injury as a predictor for influenza 
vaccination is limited.  It is possible that the school absenteeism was a proxy for 
underlying health condition or that vaccine acceptance was linked with amount of 
absenteeism caused by influenza-like illness prior to the survey [61]. However, it is 
important to note the survey did not distinguish between illness or injury in the study, and 
the proportion of the two categories is unknown. It is also unclear the type or pattern 
(consecutive versus intermittent) of the illness the teen reported experiencing and if the 
illness reported were attributed any significant underlying health conditions. Perhaps a 
more appropriate variable might have assessed the number of missed school days due to 
influenza-like illness. Further research is needed to better understand the association 
between the number of missed school days and influenza vaccination. 
 Maternal Socio-demographic Characteristics  
        Mother’s Age 
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       Results from this analysis revealed that maternal age was a statistically significant 
predictor for receipt of influenza vaccination in this study population. Teens who had 
mothers in the 35 to 44 and 45 and older age groups were less likely to receive the 
influenza vaccine compared with the referent 34 and younger age group. Previous studies 
have revealed mixed findings for the association between maternal age and immunization 
[62].  Some studies have indicated that children of younger mothers are at increased risk 
of underimmunization while other studies have shown no association [62]. One study, 
however, has shown that maternal age was an important facto associated with up-to-date 
vaccination coverage of children 19-35 months of age  in the U.S. for children born to 
mothers age 26 and younger [62]. One possibility for the findings in this study is that 
mothers in the older age groups were adolescents themselves during the 1976 swine 
influenza epidemic and may have recall the increased frequency of Guillain-Barré 
Syndrome associated with the vaccine [13]. A parent’s personal experiences with the 
influenza vaccination could certainly have shaped their attitudes about vaccination for the 
adolescents in this study. Another possibility is that an older mother may indicate the 
possibility of the mother having more children in the household. Having additional 
children may require additional support and encouragement regarding vaccination [24]. 
Further studies should assess the association between maternal age, maternal experiences 
with vaccination, and receipt of influenza vaccination.  
Mother’s Education Level 
    Although odds ratios from the bivariate analysis suggested that teens who had 
mothers who obtained higher levels of education were more likely to receive the 
influenza vaccination, results from the multivariate analysis revealed that that maternal 
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education level was not a statistically significant predictor for receipt of influenza 
vaccination in this study population. Previous studies have shown mixed findings. In one 
study, it was found that lower maternal education is associated with undervaccination and 
improving the educational status of both parents could potentially improve the 
immunization coverage of children [24, 63].Another study has found that children of 
mothers who were less educated were more likely to have completed the childhood 
4:3:1:3 series [64]. It is also important to recognize that education level also may have 
been proxy for socioeconomic status since higher education levels could indicated higher 
paying jobs.  Additional research in needed to assess the association between maternal 
education level and receipt of influenza vaccination.  
Mother’s Marital Status  
Results from this analysis revealed that after adjusting for other variables, 
mother’s marital status was not a statistically significant predictor for receipt of influenza 
vaccination. Studies have suggested that those who are separated or divorced suffered the 
most negative health outcomes as well were more likely to have children who were 
undervaccinated [24, 65]. Although results from this study did not find statistical 
significance in mother’s marital status, it is still important for public health practitioners 
to recognize that mothers are influential in the vaccination of their children and that 
public health interventions should still address maternal concerns and barriers [24].  
Further studies should seek to investigate the association of parental marital status, 
medical care, and receipt of influenza vaccination.  
5.2 Study Limitations 
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The results of this study are subject to some limitations. First, this study only 
extracted data on influenza vaccination status data from a parent’s or guardian’s recall 
based on telephone surveys, and responses from participants may reflect recall bias. 
Analysis using only the population with vaccination shot card or verification from 
provider was not incorporated for this study. In addition, although mothers are influential 
in the vaccination of their children and although a higher percentage of respondents were 
mothers, the actual impact of maternal socio-demographic characteristics in this study 
population is unknown.  
In addition, another component to the recall bias is that the NIS survey was conducted 
throughout the calendar year and included three different influenza vaccination seasons 
(2006-2007, 2007-2008 and 2008-2009 seasons). The influenza vaccine is administered 
annually in a fairly limited time period, and it is possible that respondents who were 
surveyed closer to the influenza season were more likely to recall the status of the teen’s 
immunization status. Also, because ACIP recommendation to vaccinate children ages 5-
18 had not been included until the 2008-2009 influenza season [66], there could have 
been differences in the response of households between the different seasons, but the 
impact of the changes in recommendation to providers and parents was not assessed. 
Secondly, although the data on type, place, and month of influenza vaccination can be 
important in assessing trends, the reason for the large portion of missing data in this study 
population is unknown. Lastly, because the NIS is a telephone survey, vaccination, 
demographic, and socioeconomic data on households that strictly use cellular telephones 
would not have been captured.  
51 
 
      Another limitation is the design of the study itself. Although associations of many 
socio-demographic characteristics and household-reported health status with influenza 
vaccine receipt could be assessed, the cross-sectional design of the study was not strong 
enough to enable an analysis of direct causation for these variables and vaccine 
prevalence. Second, unlike other vaccines (HPV, MMR, etc) surveyed in the NIS, the 
reasons for decline of receipt of the influenza vaccine were not assessed.  The reason for 
not incorporating a “reasons for decline of receipt” section in the survey is unknown. 
   Although health insurance status was found to be a significant predictor, a large 
percentage of data on health insurance status was not available either due to unknown or 
non-response.  Questions from the health insurance status section were addresses towards 
the end of the interview, and some respondents who did not complete the demographic 
section earlier in the survey did not reach the health insurance questions. The NIS 
researchers also addressed the possibility that respondents who began the health 
insurance questions may have broke off the interview prior to concluding the survey. It is 
also unknown whether the teen’s health insurance covered the entire or a portion of the 
cost of receiving the vaccine.  
The household-reported health status variables also present a limitation. The data 
collected on asthma status and underlying health conditions were self-reported and 
responses were not verified by licensed health professionals or the teen’s health care 
providers. Also, the data collected on number of missed school days due to illness or 
injury was not verified by school officials. Respondents may have reported the teen as 
having an underlying health condition when in fact he or she may have a medical issue 
not known to put them at high risk for influenza complication. Therefore, errors due to 
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both recall and information bias were both possible and unavoidable. As mentioned 
earlier, the number of missed school days did not distinguish between illness or injury 
and the proportion of the two components is unknown. It is quite possible those who 
reported a significant number of missed school days were mainly attributed to extensive 
injuries.   
5.3 Recommendations 
Additional research is needed to address the limitations mentioned above. 
Additional studies should evaluate the population with shot cards, include questions 
which directly assess the reasons for or against influenza vaccination, and questions 
which survey provider recommendations and parental knowledge of influenza vaccines.  
 A follow-up study on the population with vaccination shot cards and provider 
verification should be considered. Verification of vaccination status from primary care 
providers or health departments would help reduce the recall bias but would also confirm 
other important factors related to influenza vaccination such as place and time of 
vaccination. Verification of underlying health condition by the health a health care 
provider not only could also help reduce recall bias, but also would help improve our 
understanding of the adolescent population who is at high-risk for influenza vaccination.  
 The NIS surveyed reasons for the decline of the receipt of the meningitis, Human 
Papillomavirus, and tetanus vaccines. These included not believing in vaccines, costs, 
safety concerns, and lack of knowledge, etc. and should also be addressed with the 
influenza vaccine. The fear of needles or injection has been also cited as a reason for 
declining receipt of influenza vaccination and should be considered in future 
research[39]. It is also unknown the population of teens who declined of the receipt of the 
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influenza vaccine due to contraindication. Additional investigation should also seek 
reasons for the large amount of data on type, month, and place of influenza vaccine was 
not collected. It may also help to survey those who did receive the influenza vaccination 
and determine reasons the teens and families pursued receipt of influenza vaccination.  
Additional research which assesses reasons for or against influenza vaccination in 
combination with socio-demographic characteristics and health status would assist public 
health professionals and medical professional in recognizing both strategies to enhance 
vaccination as well as areas for improvement in vaccination coverage.  
 Another important aspect to socio-demographic characteristics would be the 
actual costs, time, and transportation needs in order to access preventative health services 
and vaccination. Assessing the distance and availability of facilities which offer health 
care services would also be helpful. Although VFC and many health insurance policies 
cover the costs of vaccinations, the survey does not capture whether parental 
inconvenience was a barrier to vaccination in this study population. Children of parents 
of low-income working families may be especially vulnerable to under-vaccination or 
lack of vaccination as it is often the parents who must take the time to schedule medical 
appointments, drive their children to the clinic or hospital in order to receive the vaccines, 
and follow-up with any post-vaccination adverse events.  
 The survey also did not assess whether providers recommended the vaccine to the 
teen. Previous studies have shown that recommendations from primary care providers 
increased childhood influenza vaccination rates [47]. Health care providers may not be 
vaccinated for influenza themselves and may not proactively recommend the influenza 
vaccine [14]. Recall or reminder systems established by the provider could also be 
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considered a form of recommendation from health care providers. Although assessing 
recommendations by health care providers would not include families who do not have 
access to care, additional research on whether health care providers recommend the 
vaccine in combination with socio-demographic characteristics should still highlight 
opportunities to enhance vaccination education to both parents and health care providers.  
Finally, another unfortunate known barrier to influenza vaccination is the belief 
by parents that the vaccine causes the disease [47]. Parental knowledge of the types of 
vaccination available (shot versus mist), when to obtain the vaccination, and the benefits 
and risks of influenza vaccination should be assessed. Parental knowledge and 
perceptions that obtaining the influenza vaccine is beneficial increases childhood 
influenza vaccination rates[47]. The limited data collected on influenza vaccine type, the 
month and place the vaccine was administered highlights opportunities to assess 
important trend in influenza vaccination and identify gaps in parental knowledge.  
5.4 Conclusion 
 The 2009 H1N1 virus caused the first influenza pandemic since 1968, and 
contrary to what had been predicted, North America, not Southeast Asia was the 
epicenter of the pandemic. This highlights the need for pandemic response preparedness 
by public health professionals, health care providers, media, policy makers, as well as the 
general public. Ensuring an adequate vaccination supply and providing updated 
vaccination recommendations should also be a priority in preparing for both influenza 
epidemics and pandemics. Although influenza-associated pediatric mortality is rare, the 
disease still contributes to relatively high rates of emergency department visits, outpatient 
55 
 
visits, and hospitalizations [11, 67]. Influenza vaccination rates among both healthy 
adolescents and adolescents with underlying health condition are still low. 
    Given the findings of significant associations between socio-demographic 
characteristics and household-reported health status in this study and that adolescents are 
the next generation of parents, further research needs to consider adolescent socio-
demographic factors as a determinant when surveying immunization coverage against 
influenza. Although the current influenza vaccine recommendations now include all 
individuals ages 6 months and older, it should still be important to recognize and reduce 
health disparities and inequalities which contribute to non-vaccination or under-
vaccination. Improved understanding of demographic and socioeconomic characteristics, 
as well as existing underlying health conditions, will facilitate the path to improving 
interventions, vaccination rates, and subsequent reduction in the burden of disease.  
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